background
meticillinresist
staphylococcu
aureu
mrsa
entrench
singapor
hospit
sinc
excess
nondupl
case
infect
bacteraemia
episod
year
univers
hospit
approxim
hospit
bed
use
isol
facil
aim
studi
impact
mrsa
control
bundl
implement
via
gradual
geograph
extens
across
hospit
ward
method
bundl
includ
activ
surveil
admiss
transferdischarg
identifi
wardbas
acquisit
mrsa
isol
cohort
mrsainfect
patient
enhanc
hand
hygien
initi
publicli
display
feedback
mrsa
acquisit
hand
hygien
complianc
rate
implement
octob
june
order
provid
leadtim
increment
develop
infrastructur
capac
develop
ethic
infect
prevent
among
staff
result
analys
via
interrupt
timeseri
analysi
find
mrsa
infect
fell
midway
implement
mrsa
bacteraemia
declin
confid
interv
ci
case
per
inpatientday
first
quarter
ci
case
per
inpatientday
first
quarter
mrsa
acquisit
rate
fell
year
programm
fulli
implement
wherea
hand
hygien
complianc
rose
significantli
ci
first
quarter
ci
first
quarter
conclus
success
stage
implement
mrsa
bundl
hyperendem
set
sustain
repres
model
may
adapt
similar
set
sustain
meticillinresist
staphylococcu
aureu
control
hyperendem
tertiari
acut
care
hospit
infrastructur
challeng
singapor
introduct
sinc
worldwid
establish
healthcareassoci
meticillinresist
staphylococcu
aureu
mrsa
sustain
reduct
demonstr
sever
part
world
netherland
maintain
mrsa
level
manag
outbreak
success
use
search
destroy
polici
scandinavian
countri
western
australia
cite
similar
success
stori
veteran
affair
chain
hospit
usa
establish
mrsa
bundl
report
across
australia
franc
uk
also
shown
signific
reduct
mrsa
infect
last
year
effect
intervent
control
mrsa
transmiss
hospit
set
well
known
includ
activ
surveil
improv
hand
hygien
complianc
isol
mrsa
case
wherea
gener
strategi
obtain
focus
commit
hospit
leadership
critic
toward
lower
implement
barrier
improv
sustain
success
rare
asia
part
world
mrsa
hyperendem
high
antimicrobi
resist
rate
nosocomi
bacteria
result
competit
limit
resourc
isol
facil
e
infrastructur
hurdl
difficult
overcom
estim
burden
mrsa
singapor
nation
univers
hospit
singapor
nuh
publish
separ
report
describ
issu
microbiolog
clinic
mrsa
infect
includ
least
bloodstream
infect
previous
seen
per
year
nuh
sheer
volum
case
coupl
infrastructur
societ
constraint
tradit
hinder
mrsa
control
effort
bed
avail
contact
isol
despit
neg
pressur
isol
room
built
sever
acut
respiratori
syndrom
sar
outbreak
insuffici
capac
isol
mrsa
patient
constitut
inpati
priorit
mrsa
would
impair
abil
isol
cohort
patient
transmiss
diseas
ad
problem
averag
daili
bed
occup
rate
exceed
e
result
recent
rapid
popul
boom
singapor
senior
hospit
manag
nuh
respons
endem
rate
mrsa
infect
larg
number
clinic
infect
call
aggress
respons
describ
strategi
contain
mrsa
hyperendem
hospit
infrastructur
constraint
implement
well
analys
impact
via
timeseri
analysi
conduct
prospect
interrupt
timeseri
studi
nuh
e
acut
care
tertiari
univers
singapor
intervent
describ
implement
via
gradual
geograph
extens
octob
june
intervent
compris
seri
mrsa
control
measur
put
togeth
bundl
includ
activ
surveil
mrsa
carriag
consist
swab
nare
axilla
groin
plu
wound
cultur
chromogen
agar
mrsa
select
biorad
laboratori
marneslacoquett
franc
patient
known
mrsa
entri
swab
hospit
ward
h
prior
posit
mrsa
cultur
screen
clinic
die
also
exit
swab
upon
discharg
transfer
ward
promot
hand
hygien
done
primarili
via
educ
sociobehaviour
measur
hand
hygien
educ
focus
world
health
organ
five
moment
hand
hygien
audit
continu
remind
develop
includ
via
poster
ward
comput
screensav
audio
ward
entri
hospitalwid
train
programm
ran
annual
coincid
world
hand
hygien
day
frontlin
clinic
staff
particip
compulsori
min
train
programm
assess
one
week
year
sticker
place
staff
identif
tag
confirm
certif
new
staff
receiv
programm
orient
reinforc
messag
clinic
examin
templat
nation
univers
singapor
final
mbb
degre
stipul
deduct
mark
fail
hand
hygien
audit
hand
hygien
complianc
perform
primarili
appoint
ward
liaison
nurs
train
infect
control
nurs
supplement
crosscheck
medic
nurs
student
engag
via
innov
educ
programm
train
auditor
observ
staff
work
covertli
isol
cohort
mrsaposit
patient
patient
place
isol
usual
design
cohort
cubicl
establish
ward
period
snapshot
cohort
complianc
undertaken
close
relationship
bed
manag
unit
project
stakehold
develop
facilit
site
mrsaposit
patient
public
regular
feedback
result
data
hand
hygien
complianc
mrsa
acquisit
post
wardbas
dashboard
request
hospit
administr
signag
publicli
display
wardspecif
updat
monthli
measur
includ
barebelowtheelbow
polici
clinic
staff
colour
bracelet
identifi
colon
infect
patient
cash
reward
around
us
exemplari
perform
ward
depart
regard
hand
hygien
complianc
mrsa
transmiss
rate
enjoy
celebratori
lunch
similar
ensur
progress
made
primarili
due
mrsa
bundl
chang
prescrib
habit
surveil
major
class
antibiot
fluoroquinolon
carbapenem
third
fourth
gener
cephalosporin
vancomycin
undertaken
use
pharmacybas
electron
data
express
defin
daili
dose
ddd
per
inpatientday
order
fulli
implement
mrsahyperendem
hospit
infrastructur
resourc
constraint
mrsa
bundl
implement
via
plan
gradual
geograph
extens
year
e
ward
time
would
allow
leadtim
increment
develop
infrastructur
capac
number
area
includ
number
microbiolog
laboratori
technic
staff
infect
control
data
manag
system
also
believ
gradual
introduct
would
help
growth
ethic
infect
prevent
among
staff
improv
odd
sustain
two
action
undertaken
simultan
first
overal
mrsa
taskforc
form
includ
member
senior
hospit
manag
compris
chair
medic
board
chief
oper
offic
director
nurs
infect
control
chair
fulltim
mrsa
data
manag
among
other
second
assess
local
clinic
econom
impact
mrsa
infect
undertaken
key
indic
improv
includ
collect
indic
would
repres
overal
burden
mrsa
infect
institut
likelihood
mrsa
acquisit
patient
hospit
overal
infect
control
adher
among
healthcar
staff
process
indic
includ
cohort
complianc
rate
activ
surveil
test
rate
well
result
hand
hygien
complianc
audit
preliminari
analysi
preintervent
timeseri
yield
nonsignific
autoregress
coeffici
suggest
observ
autocorrel
lag
across
entir
timeseri
result
gradual
chang
diseas
incid
rather
inher
correl
timewindow
subsequ
analysi
account
autocorrel
model
chang
mean
incid
proport
function
time
number
mrsa
clinic
case
mrsa
bacteraemia
case
per
quarter
model
poisson
mean
per
hospit
inpatientday
extend
model
neg
binomi
account
superpoisson
heterogen
improv
fit
quarterli
number
posit
exit
swab
among
initi
noncolon
patient
assum
binomi
proport
p
model
use
linear
log
logit
scale
chang
locat
time
singl
chang
gradient
allow
number
mrsa
bacteraemia
case
model
form
log
quantifi
averag
incid
tempor
chang
point
b
g
character
perquart
increas
decreas
incid
true
otherwis
similar
model
replac
log
logit
p
use
withinhospit
colon
handwash
perform
paramet
b
g
infer
independ
timecours
intervent
therebi
assess
plausibl
intervent
coincid
infer
changepoint
likelihood
surfac
suggest
maximum
likelihood
estim
particular
may
normal
distribut
bayesian
method
use
deriv
confid
interv
ci
take
uniform
prior
distribut
paramet
support
use
markov
chain
mont
carlo
sampler
sampl
everi
retain
multivari
normal
propos
covari
tune
trial
run
approxim
pvalu
obtain
extend
credibl
interv
analog
relationship
pvalu
endpoint
confid
interv
point
estim
report
maximum
likelihood
estim
posterior
mode
analysi
perform
r
statist
environ
programm
initi
octob
singl
orthopaed
ward
follow
subsequ
rollout
target
ward
within
hospit
complet
june
figur
end
june
adult
intens
care
unit
gener
ward
includ
major
surgic
gener
ward
includ
programm
figur
show
incidencedens
mrsa
clinic
isol
sinc
mrsa
blood
isol
sinc
mrsa
acquisit
rate
sinc
strong
evid
rise
incid
mrsa
clinic
case
peak
first
quarter
ci
notabl
declin
thereaft
figur
peak
consist
complet
rollout
end
second
quarter
p
first
rollout
programm
fourth
quarter
p
declin
changepoint
time
ci
rapid
preced
rise
mrsa
acquisit
rate
present
figur
empir
model
mrsa
bacteraemia
rate
present
figur
signific
fall
case
ci
per
inpatientday
first
quarter
case
ci
first
quarter
evid
fall
level
ci
changepoint
span
almost
entir
period
record
data
evolut
hand
hygien
complianc
display
figur
complianc
rose
significantli
sinc
audit
start
ci
first
quarter
ci
first
quarter
howev
evid
complianc
stall
around
last
quarter
ci
rate
chang
time
statist
distinguish
p
throughout
period
studi
chang
consumpt
antibiot
measur
correl
improv
mrsa
rate
figur
therefor
antibiot
prescript
per
se
affect
mrsa
rate
institut
result
reinforc
concept
mrsa
bundl
compris
standard
wellknown
mrsa
control
measur
abl
bring
mrsa
transmiss
infect
rate
substanti
even
set
mrsa
hyperendem
studi
shown
signific
declin
mrsa
acquisit
clinic
specimen
also
bacteraemia
concurr
declin
antibiot
prescrib
habit
ad
likelihood
intervent
caus
mrsa
improv
fact
vancomycinresist
enterococci
clostridium
difficil
rate
increas
hospit
unpublish
data
multidrugresist
gramneg
infect
rate
remain
stabl
approach
perhap
extrapol
similar
set
show
implement
barrier
term
manpow
cultur
infrastructur
constraint
overcom
use
gradual
stage
rollout
mrsa
bundl
activ
involv
senior
hospit
manag
kotter
broadli
map
process
initi
sustain
chang
effort
decad
ago
sustain
critic
effort
requir
cultur
chang
data
manag
commun
key
sustain
chang
one
fulltim
member
staff
appoint
collat
feed
perform
metric
back
wardbas
healthcar
worker
nurs
manag
infect
control
team
senior
manag
wardspecif
hand
hygien
complianc
data
train
auditor
mrsa
acquisit
rate
post
graphic
quarter
publicli
display
dashboard
ward
effort
toward
prevent
mrsa
acquisit
infect
becom
embed
cultur
clinic
medicin
nuh
plateau
seen
data
signific
gain
suggest
improv
sustain
better
result
unlik
absenc
intervent
potenti
intervent
beyond
alreadi
implement
includ
relat
technolog
advanc
cut
edg
research
screen
healthcar
staff
implement
oper
concern
e
signific
proport
staff
like
colon
would
imposs
lay
work
period
requir
mrsa
decolon
well
concern
mrsa
recolon
would
common
hyperendem
set
nonetheless
consid
futur
mrsa
rate
fail
declin
decolon
patient
staff
remain
controversi
beyond
preoper
indic
work
regard
underway
institut
conceiv
reduc
reservoir
mrsa
may
prevent
transmiss
therefor
infect
rate
predict
develop
mupirocin
resist
particular
concern
evalu
carbapenem
use
altern
agent
anoth
prioriti
research
mrsa
control
global
current
effort
labourintens
carri
risk
fatigu
mainten
data
allow
track
progress
may
help
prevent
histori
repeat
trend
toward
origin
baselin
appear
patient
colon
develop
infect
invis
absenc
activ
surveil
monitor
acquisit
without
infect
allow
upstream
view
progress
infect
control
intervent
manual
hand
hygien
audit
use
train
auditor
ineffici
labour
intens
made
inaccur
hawthorn
effect
necessarili
small
sampl
size
gener
weekday
daytim
hour
technolog
solut
evolv
could
potenti
featur
infect
control
programm
tomorrow
function
evid
costeffect
remain
barrier
technolog
activ
surveil
test
cornerston
bundl
wherea
use
culturebas
techniqu
molecular
test
would
time
sensit
albeit
carri
risk
region
set
potenti
miss
certain
mrsa
strain
argininecatabol
mobil
element
acm
insert
orfx
incur
greater
oper
cost
sever
limit
work
first
nonrandom
beforeandaft
studi
design
involv
singl
institut
howev
common
issu
infect
control
studi
one
easili
overcom
natur
studi
period
concomit
decreas
nosocomi
antibioticresist
pathogen
carbapenemresist
acinetobact
baumannii
extendedspectrum
betalactamaseproduc
enterobacteriacea
data
shown
would
suggest
overal
declin
antimicrobi
resist
rate
clinic
practic
also
chang
substanti
second
natur
intervent
sever
measur
includ
singl
bundl
individu
effect
measur
determin
nonetheless
care
bundl
accept
clinic
practic
effect
greater
collect
introduc
separ
measur
conclus
hospit
confront
hyperendem
mrsa
high
infect
rate
infrastructur
andor
resourc
constraint
introduc
sustain
improv
provid
proactiv
team
includ
senior
manag
leadership
drive
data
mainten
process
outcom
measur
good
commun
essenti
